Patient adherence and reimbursement amount for antidiabetic fixed-dose combination products compared with dual therapy among texas medicaid recipients
- 31 October 2008
- journal article
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 30 (10), 1893-1907
- https://doi.org/10.1016/j.clinthera.2008.10.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Variation in pharmacy prescription refill adherence measures by type of oral antihyperglycaemic drug therapy in seniors in Nova Scotia, CanadaJournal of Clinical Pharmacy & Therapeutics, 2002
- Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort studyDiabetic Medicine, 2002
- Adherence to oral antidiabetic therapy in a managed care organization: A comparison of monotherapy, combination therapy, and fixed-dose combination therapyClinical Therapeutics, 2002
- Effects of Once-Daily and Twice-Daily Dosing on Adherence With Prescribed Glipizide Oral Therapy for Type 2 DiabetesSouthern Medical Journal, 2002
- Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitusClinical Therapeutics, 2001
- Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)JAMA, 1999
- Compliance with sulfonylureas in a health maintenance organization: a pharmacy record-based study.Annals of Pharmacotherapy, 1999
- UKPDS 28: A Randomized Trial of Efficacy of Early Addition of Metformin in Sulfonylurea-Treated Type 2 DiabetesDiabetes Care, 1998
- Impact of Dosage Frequency on Patient ComplianceDiabetes Care, 1997
- Efficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1995